Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6228481 | 0.87 | MAPT (0.36) | PDE4ALMNAL3MBTL1 | |
| Acetone SCHEMBL28329344 | 0.84 | MAPT (0.34) | LMNA | |
| SCHEMBL17767399 | 0.84 | PAX8 (0.38) | PDE4ALMNAL3MBTL1USP2SLCO1B1 | |
| SCHEMBL9225414 | 0.82 | MAPT (0.53) | LMNA | |
| SCHEMBL9227207 | 0.82 | MAPT (0.53) | LMNA | |
| SCHEMBL4606284 | 0.81 | — | — | |
| SCHEMBL5448988 | 0.81 | PDE4A (0.31) | PDE4ALMNAL3MBTL1 | |
| SCHEMBL16144867 | 0.80 | PDE4A (0.40) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL28085202 | 0.79 | USP2 (0.36) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL5685647 | 0.79 | USP2 (0.36) | PDE4ALMNAL3MBTL1TDP1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050058611-A1 | Preventing and/or combating collagen fiber degradation induced under conditions of natural exposure to sunlight | L'OREAL (FR) | 2005-03-17 | — | — | US | disclosed |
| EP-1508328-A1 | Composition against the degradation of fibres of collagen induced in condition of natural solar exposure | L'OREAL (FR) | 2005-02-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050058611-A1 | Preventing and/or combating collagen fiber degradation induced under conditions of natural exposure to sunlight | COL14A1, COL2A1, COL1A1 | PDE4A 2732/4885LMNA 176/4885L3MBTL1 4595/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.